BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3535930)

  • 21. Successful allogeneic hematopoietic stem cell transplantation using triple agent immunosuppression in severe aplastic anemia patients.
    Kim HJ; Park CY; Park YH; Kim YJ; Kim DW; Min WS; Kim CC
    Bone Marrow Transplant; 2003 Jan; 31(2):79-86. PubMed ID: 12621487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marrow transplantation in hepatitis-associated aplastic anemia.
    Witherspoon RP; Storb R; Shulman H; Buckner CD; Deeg HJ; Clift RA; Sanders JE; Doney K; McDonald G; Sullivan KM
    Am J Hematol; 1984 Oct; 17(3):269-78. PubMed ID: 6383025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
    Kiem HP; McDonald GB; Myerson D; Spurgeon CL; Deeg HJ; Sanders JE; Doney K; Appelbaum FR; Sullivan KM; Witherspoon RP; Storb R
    Biol Blood Marrow Transplant; 1996 May; 2(2):93-9. PubMed ID: 9118304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of the relative response index with marrow graft rejection in patients with aplastic anemia.
    Mickelson EM; Fefer A; Storb R; Thomas ED
    Transplantation; 1976 Sep; 22(3):294-302. PubMed ID: 135386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection.
    Dulley FL; Vigorito AC; Aranha FJ; Sturaro D; Ruiz MA; Saboya R; Macedo MC; Da Silva RL; Chamone DA; Mehta J; Bacigalupo A; De Souza CA
    Bone Marrow Transplant; 2004 Jan; 33(1):9-13. PubMed ID: 14578930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Supplemental peripheral blood stem cells to decrease marrow rejection in adult patients with severe aplastic anemia.
    Min CK; Kim DW; Lee JW; Han CW; Min WS; Kim CC
    Am J Hematol; 2002 Jan; 69(1):15-22. PubMed ID: 11835325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results.
    Champlin RE; Horowitz MM; van Bekkum DW; Camitta BM; Elfenbein GE; Gale RP; Gluckman E; Good RA; Rimm AA; Rozman C
    Blood; 1989 Feb; 73(2):606-13. PubMed ID: 2644980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic transplantation using CD34
    Purev E; Tian X; Aue G; Pantin J; Vo P; Shalabi R; Reger RN; Cook L; Ramos C; Cho E; Worthy T; Khuu H; Stroncek D; Young NS; Childs RW
    Br J Haematol; 2017 Mar; 176(6):950-960. PubMed ID: 28169418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor.
    Lohrmann HP; Dietrich M; Goldmann SF; Kristensen T; Fliedner TM; Abt C; Pflieger H; Flad HD; Kubanek B; Heimpel H
    Blut; 1975 Dec; 31(6):347-54. PubMed ID: 1127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.
    Storb R; Prentice RL; Buckner CD; Clift RA; Appelbaum F; Deeg J; Doney K; Hansen JA; Mason M; Sanders JE; Singer J; Sullivan KM; Witherspoon RP; Thomas ED
    N Engl J Med; 1983 Feb; 308(6):302-7. PubMed ID: 6337323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic bone marrow transplantation for fourteen patients with severe aplastic anemia.
    Hsueh EJ; Hwang WS; Huang SH; Chao TY; Chang JY; Wang CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Apr; 57(4):247-53. PubMed ID: 8705875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single centre experience with allogeneic stem cell transplantation for severe aplastic anaemia in childhood.
    Ladenstein R; Peters C; Minkov M; Emminger-Schmidmeier W; Mann G; Höcker P; Hawliczek R; Rosenmayr A; Fink FM; Niederwieser D; Gadner H
    Klin Padiatr; 1997; 209(4):201-8. PubMed ID: 9293451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation for severe aplastic anemia--a study of twenty-one Chinese patients in Taiwan.
    Tzeng CH; Hsieh RK; Fan S; Liu JH; Liu JM; Liu CJ; Chen KY; Yung CH; Wang SY; Wang SR
    Transplantation; 1992 Mar; 53(3):569-74. PubMed ID: 1549848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?
    Gallo S; Woolfrey AE; Burroughs LM; Storer BE; Flowers ME; Hari P; Pulsipher MA; Heimfeld S; Kiem HP; Sandmaier BM; Storb R
    Bone Marrow Transplant; 2016 Dec; 51(12):1573-1578. PubMed ID: 27479689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow transplantation for severe aplastic anemia. A report of 9 cases.
    Marmont AM; Van Lint MT; Avanzi G; Reali G; Adami R; Soldá A; Strada P; Barbanti M; Mingari MC; Soro O; Grazi G; Pedullá D; Cerri R; Rossi E; Giordano D; Santini G; Carella A; Risso M; Vimercati R; Piaggio G; Raffo MR; Librace E; Vitale V; Bacigalupo A
    Acta Haematol; 1979; 62(3):121-7. PubMed ID: 43062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
    Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA-matched sibling transplantation with BM and CD34(+)-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.
    Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Min WS; Park CW; Kim CC; Lee JW
    Bone Marrow Transplant; 2010 Oct; 45(10):1497-501. PubMed ID: 20062099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection.
    Storb R; Prentice RL; Thomas ED
    N Engl J Med; 1977 Jan; 296(2):61-6. PubMed ID: 136605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience.
    Hernández-Boluda JC; Marín P; Carreras E; Aguilar JL; Grañena A; Rozman C; Montserrat E
    Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.